Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers (PCS IV)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00223171 |
|
Recruitment Status : Unknown
Verified May 2022 by Abdenour Nabid, Centre de recherche du Centre hospitalier universitaire de Sherbrooke.
Recruitment status was: Active, not recruiting
First Posted : September 22, 2005
Last Update Posted : May 26, 2022
|
Sponsor:
Université de Sherbrooke
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Abdenour Nabid, Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 31, 2023 |
| Estimated Study Completion Date : | December 31, 2023 |